Your browser doesn't support javascript.
loading
Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment.
Bolhuis, Mathieu S; Akkerman, Onno W; Sturkenboom, Marieke G G; Ghimire, Samiksha; Srivastava, Shashikant; Gumbo, Tawanda; Alffenaar, Jan-Willem C.
Afiliação
  • Bolhuis MS; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen.
  • Akkerman OW; Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen.
  • Sturkenboom MGG; Tuberculosis Center Beatrixoord, University Medical Center Groningen, University of Groningen, Haren, The Netherlands.
  • Ghimire S; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen.
  • Srivastava S; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen.
  • Gumbo T; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
  • Alffenaar JC; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
Clin Infect Dis ; 67(suppl_3): S327-S335, 2018 11 28.
Article em En | MEDLINE | ID: mdl-30496467

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Linezolida / Antituberculosos Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Linezolida / Antituberculosos Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article